SCHEMBL20041858

SCHEMBL20041858

CCN1C[C@@H](c2ccc(OC)cc2)CC1=O

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
PDE4A P27815 4/20 0.48
PDE4B Q07343 2/20 0.48
PDE4C Q08493 2/20 0.48
PDE4D Q08499 2/20 0.48
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
ADRA1A P35348 1/20 0.46
DRD2 P14416 1/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
HTT P42858 1/20 0.42
BRD4 O60885 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19559408 1.00 SMN1; SMN2 (0.49) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19559539 0.84 FPR1 (0.53) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19559566 0.83 SMN1; SMN2 (0.60) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19559404 0.82 SMN1; SMN2 (0.53) SMN1; SMN2TSHRKMT2AMEN1ALDH1A1
SCHEMBL13532862 0.81 HPGD (0.69) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL10762307 0.81 HPGD (0.69) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL19559517 0.80 SMN1; SMN2 (0.62) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL6558457 0.80 PDE4A (0.66) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL18117748 0.80 PDE4A (0.66) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL28949764 0.79 HPGD (0.74) SMN1; SMN2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305763-A1 DEUTERATED OR ISOTOPICALLY LABELED UREA DERIVATIVES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF USEFUL AS FPRL-1 AGONISTS Kyorin Pharmaceutical Co., Ltd. (JP) 2018-04-11 EP disclosed